ALTG vs XRX

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and profitability deterioration. Despite a bullish analyst recommendation and a high dividend yield, the company is deeply unprofitable (ROE: -160.65%, Profit Margin: -4.34%), leveraged excessively (Debt/Equity: 420.97), and has consistently missed earnings estimates by wide margins. Revenue is declining, cash flow metrics are unavailable, and the Price/Book ratio of 71.44 suggests extreme overvaluation relative to book value. While the stock has rallied 36.8% in the last month, long-term performance remains deeply negative with a 5Y change of -32.2%, raising concerns of speculative momentum rather than fundamental recovery.

XRX exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic ROE of -104.10%. While the stock trades at a deep discount to book value (P/B 0.48) and shows surprising revenue growth, these are classic 'value trap' indicators given the extreme leverage (Debt/Equity 6.81) and consistent earnings misses. The technical trend is completely bearish (0/100), and the dividend is unsustainable with a 94.34% payout ratio. Overall, the company appears to be in a structural decline with significant insolvency risks.